1. Discure Technologies raised $16 million in Series A funding for the development of a bioelectronic implantable device for the treatment of degenerative disc disease.
2. Knee implant maker Moximed closed on a round of stock financing for up to $91 million. The funding round includes $61 million and an option to acquire an additional $30 million. The investment round was led by Elevage Medical Technologies.
3. Orthopedic implant company restor3d raised $70 million in financing to support the company’s launch of 3D-printed implant systems and investments in new technologies. The devicemaker plans to introduce new patient-specific implant systems for total ankle and shoulder replacements.
4. Lenoss Medical closed an oversubscribed series A funding round of $4 million to help accelerate commercialization of its OsteoPearl spinal allograft.
5. Miach Orthopaedics, which is behind the Bridge-Enhanced ACL restoration implant, raised $20 million in series B financing. The funds will help the company’s commercial expansion for the BEAR implant and clinical activities for it.
6. Spine devicemaker Carlsmed raised $52.5M in series C funding and will use the money to develop patient-specific cervical implants.
7. Synergy Spine Solutions, which focuses on cervical disc replacement devices, closed $30 million in series A financing that will go toward the company’s investigational device exemption 2-level clinical trial. The trial will evaluate the disc at two contiguous levels compared to anterior cervical discectomy and fusion.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
